Allergy, Asthma and Immunology et al. Diagnosis and treatment
of atopic dermatitis in children and adults: European Academy of
Allergology and Clinical Immunology / American Academy of
Allergy, Asthma and Immunology/PRACTALL Consensus
Report // J. Allergy Clin. Immunol. – 2006. – N 118. – P. 152–169.
Czarnowicki T., Krueger J.G., Guttman-Yassky E. Novel
concepts of prevention and treatment of atopic dermatitis
through barrier and immune manipulations with implications for
the atopic march // J. Allergy Clin. Immunol. – 2017. – N 139. –
P. 1723–1734.
Eichenfield L.F., Tom W.L., Berger T.G. et al. Guidelines of
care for the management of atopic dermatitis: section 2.
Management and treatment of atopic dermatitis with topical
therapies // J. Am. Acad. Dermatol. – 2014. – N 71. – P. 116–132.
Lowe A.J., Leung A.Y.M., Tang M.L.K. et al. The skin as a
target for prevention of the atopic march // Ann. Allergy Asthma
Immunol. – 2018. – N 120. – P. 145–151.
Miller J.A., Munro D.D. TCS: clinical pharmacology and
therapeutic use // Drugs. – 1980. – N 19. – P. 119–134.
Williams H.C., Burney P.G., Pembroke A.C. et al. The U.K.
Working Party’s Diagnostic Criteria for Atopic Dermatitis.
III. Independent hospital validation // Br. J. Dermatol. – 1994. –
N 131. – P. 406–416.
Достарыңызбен бөлісу: